Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 322 clinical trials
None
XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

The purpose of this study is to determine the pathological complete response rate of addition of bevacizumab to induction therapy (xelox) and concomitant treatment (capecitabine

xelox
metastasis
renal function
adenocarcinoma
bevacizumab
  • 7 views
  • 07 Nov, 2020
  • 1 location
None
Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD

The purpose of this study is to determine the association of bevacizumab and PDT is safety and effective in the treatment of exudative AMD

neovascularization
bevacizumab
corrected visual acuity
  • 10 views
  • 07 Nov, 2020
  • 1 location
None
Intravitreal Bevacizumab vs Laser vs Combination of Bevacizumab and Modified Laser in PDR

In this randomized 3-armed clinical trial, 105 eyes with PDR will be included and divided randomly into 3 groups: IVB group (35 eyes) that receive 4 monthly IVB injections and then rescue IVB, PRP group (35 eyes) that undergo full PRP in 2 or 3 sessions and then rescue IVB, …

  • 0 views
  • 23 Mar, 2021
  • 1 location
None
Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma

The purpose of this study is to determine the safety and tolerability of Regorafenib in patients with recurrent or progressive glioblastoma (GBM) who have progressed on bevacizumab. Regorafenib

gliosarcoma
cytotoxic chemotherapy
carcinoma in situ
serum pregnancy test
malignant glioma
  • 0 views
  • 04 Aug, 2021
  • 2 locations
None
Bevacizumab Treatment For Posterior Zone I ROP

Type 1 retinopathy of prematurity in zone I represents the most severe type of ROP and has the worst prognosis. It is unknown whether low-dose bevacizumab will be successful in these severe

  • 0 views
  • 17 Nov, 2021
  • 35 locations
None
Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma

This prospective phase II study is to determine the efficacy and safety of bevacizumab maintenance therapy after concurrent chemoradiotherapy in locally advanced lung adenocarcinoma

  • 0 views
  • 23 Jan, 2021
  • 1 location
None
Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

- this study is being done to find out if the combination of carboplatin and gemcitabine will be more effective in the the treatment of advanced lung cancer if bevacizumab, an

gemcitabine
bevacizumab
pleural effusion
advanced lung cancer
carboplatin
  • 3 views
  • 07 Nov, 2020
  • 1 location
None
Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy

pigment epithelial and photoreceptor damage with visual impairment. The purpose of this clinical study is report the use of intravitreal bevacizumab is a new option in the treatment of

detachment
bevacizumab
angiography
chorioretinopathy
fluorescein angiography
  • 3 views
  • 07 Nov, 2020
  • 1 location
None
Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery

This study analyzes the safety and efficacy of off-label Subconjunctival Injection of bevacizumab (Avastin) versus 0.02% mitomycin C (MMC) for preventing bleb failure following glaucoma

mitomycin
subconjunctival injection
trabeculectomy
cataract
filtration surgery
  • 28 views
  • 07 Nov, 2020
  • 1 location
None
Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome

bevacizumab in the treatment of retinopathy of prematurity

antiangiogenic therapy
bevacizumab
blindness
vascular endothelial growth factor
vegf
  • 4 views
  • 07 Nov, 2020
  • 1 location